查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1989946

血液採樣監測儀市場：依產品、血液採樣方法、應用和最終用途分類－2026-2032年全球市場預測

Blood Collection Monitor Market by Product, Collection Mode, Application, End-Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血液採樣監測儀市場價值將達到 17.1 億美元，到 2026 年將成長至 18.1 億美元，到 2032 年將達到 26.9 億美元，複合年成長率為 6.73%。

主要市場統計數據
基準年 2025 17.1億美元
預計年份：2026年 18.1億美元
預測年份 2032 26.9億美元
複合年成長率 (%) 6.73%

對目前血液採樣監測儀市場的狀況、成長要素以及相關人員為何應優先考慮創新和韌性進行簡明策略概述。

血液採集監測市場正處於臨床需求、技術能力和供應鏈現實交會的十字路口。近年來，能夠簡化血液採集流程、提高捐血者和患者安全以及將數據整合到更廣泛的臨床系統中的設備應用迅速成長。這些趨勢的驅動力在於降低血液採集結果的變異性、支持分散式醫療服務以及確保在日益複雜的醫療路徑中實現可追溯性。

推動自動化、便攜性和數據整合的關鍵變革正在重塑血液採樣監測技術和醫療保健服務模式。

隨著技術、臨床和營運要素的融合，該領域正經歷著變革性的轉變。自動化正從單一功能擴展到端到端的工作流程，從而實現更穩定的血液收集，並減輕醫護人員的認知負擔。同時，小型化和電池效率的提高使得真正可攜式的監視器成為可能，從而支持移動捐血活動、社區推廣項目以及對空間和移動性要求極高的床邊操作。

對美國近期關稅措施（截至 2025 年）如何影響醫療設備採購供應鏈和策略採購決策進行全面評估。

2025年美國關稅環境將為醫療設備製造商、經銷商和臨床採購負責人帶來新的挑戰。對某些醫療設備組件和成品徵收的關稅迫使各機構重新思考其籌資策略，重新評估供應商風險狀況，並探索本地生產和替代運輸路線以降低成本風險。儘管這些措施具有針對性，但它們對整個採購週期和庫存計劃期都產生了連鎖反應。

主導細分市場洞察產品提取方式、應用和最終用途的趨勢，指導產品策略和服務的協調。

細分市場趨勢揭示了每種產品類型、採血方式、應用場景和終端用戶環境所面臨的不同機會和營運考慮。固定式採血監視器仍然是集中式醫療機構的基礎，這些機構優先考慮處理能力和與實驗室系統的整合；而攜帶式採血監護儀則推動了外展推廣、移動捐血和床旁柔軟性等活動，在這些活動中，移動性和電池續航時間是關鍵的設計限制因素。

全球主要區域的區域趨勢揭示了血液採樣監測器的需求模式、法規環境和部署管道。

區域趨勢受醫療基礎設施、管理體制、報銷模式和專案優先事項差異的影響。在美洲，成熟的捐血網路、完善的法規結構以及對臨床資訊學的巨額投資，推動了對高通量、可互通監測器的需求。許多機構優先考慮與現有輸血和檢測系統整合、最佳化捐血流程以及支援國家血液舉措。

競爭情報與合作趨勢：揭示製造商、Start-Ups和服務供應商如何透過創新和夥伴關係進行調整。

該產業的競爭格局呈現出老牌企業佔據主導地位、新興專業參與企業嶄露頭角以及策略夥伴關係的局面。老牌醫療設備製造商憑藉著規模經濟、服務網路和現有系統整合，在需求旺盛的醫療環境中保持市場地位。同時，小規模的科技公司和Start-Ups往往在使用者介面設計、感測器整合和數據連接方面不斷進行創新，迫使老牌企業加速轉型升級。

為行業領導者提供優先考慮的、可操作的建議，以加快採用速度、降低供應鏈風險並利用新的臨床工作流程。

產業領導者應優先考慮多管齊下的方法，以平衡創新、供應鏈韌性和臨床整合。首先，投資於模組化產品架構，以便快速調整感測器、連接模組和耗材，從而滿足不同的臨床和監管需求。這種模組化設計可以縮短更新時間，並支援針對特定終端用戶環境的客製化。

採用嚴謹的調查方法，結合一手訪談、技術審查和供應鏈分析，確保獲得全面、檢驗的見解。

本研究整合了從一手訪談、技術文件審查和二手資料中獲得的定性和定量資訊，從而對該行業進行了全面的觀點。一手研究包括對採購負責人、臨床負責人、檢查室經理、設備工程師和監管專家進行結構化訪談，以了解營運重點、臨床工作流程和合規性問題。

簡明扼要的結論，整合了血液採樣監測領域中相關人員的策略意義、當前挑戰和短期優先事項。

這些分析凸顯了血液採集監測設備在現代化醫療服務和輸血系統中的策略地位。從自動化到資料整合等技術創新，為提高血液採集品質、捐血者安全和營運效率提供了切實的機會。同時，政策變化和日益複雜的供應鏈也要求制定積極主動的採購和生產策略，以維持服務的連續性並控制成本。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血液檢測儀市場：依產品分類

  • 固定式血液採樣監測儀
  • 攜帶式採血監測儀

第9章：依採集法分類的血液樣本監測市場

  • 自動化採血
  • 人工採血

第10章：血液樣本監測儀市場：依應用領域分類

  • 捐血
  • 血液保存
  • 驗血
  • 研究所

第11章：血液樣本監測儀市場：依最終用途分類

  • 門診手術中心
  • 血庫
  • 診所
  • 醫院

第12章 血液檢測儀市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 血液樣本監測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 血液檢測儀市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國血液檢測儀市場

第16章：中國血液採樣監測儀市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Becton, Dickinson and Company
  • Boeckel+Co（GmbH+Co.）KG
  • Cardinal Health Inc.
  • Delcon SRL
  • Fresenius Kabi AG
  • Greiner Group AG
  • Grifols, SA
  • GVS, SpA
  • Inspira Technologies Oxy BHN Ltd.
  • Krew Instruments Pvt Ltd
  • Kriya Medical Technologies
  • Labcold Ltd.
  • Labotronics Scientific LTD.
  • Labtop Instruments Pvt . Ltd .
  • Labtron Equipment Ltd
  • Lasany International Inc
  • Lmb Technologie GmbH
  • Medline Industries, Inc.
  • Mitra Industries
  • Narang Medical Limited
  • Nigale Biomedical Inc.（NBM）
  • Nipro Corporation
  • REMI GROUP
  • Sarstedt AG & Co. KG
  • Terumo Medical Corporation
Product Code: MRR-CD5A9334D011

The Blood Collection Monitor Market was valued at USD 1.71 billion in 2025 and is projected to grow to USD 1.81 billion in 2026, with a CAGR of 6.73%, reaching USD 2.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.71 billion
Estimated Year [2026] USD 1.81 billion
Forecast Year [2032] USD 2.69 billion
CAGR (%) 6.73%

A concise strategic overview introducing the blood collection monitor landscape its evolving drivers and why stakeholders must prioritize innovation and resilience

The blood collection monitor landscape is at an inflection point where clinical demands, technological capability, and supply chain realities intersect. Recent years have seen an acceleration in the adoption of devices that streamline collection workflows, improve donor and patient safety, and integrate data into broader clinical systems. These trends are driven by a desire to reduce variability in collection outcomes, support decentralized care delivery, and ensure traceability across increasingly complex care pathways.

Concurrently, stakeholders face heightened regulatory scrutiny, tighter quality expectations, and evolving protocols for infection control and sample integrity. As a result, procurement and clinical teams must balance usability, interoperability, and total lifecycle considerations when evaluating devices. This report distills those dynamics into actionable insight, highlighting where innovation is occurring, which operational constraints persist, and how decision-makers can align technology choices with institutional goals and patient-centered outcomes.

In short, the introduction frames the critical forces affecting product design, clinical adoption, and supply relationships, setting the stage for deeper examination of technological inflection points and strategic responses required across the ecosystem.

Critical transformative shifts reshaping blood collection monitoring technologies and care delivery models driven by automation portability and data integration

The sector is undergoing transformative shifts driven by converging technological, clinical, and operational forces. Automation is expanding from discrete functions into end-to-end workflows, enabling more consistent collection events and reducing the cognitive load on staff. At the same time, miniaturization and battery efficiency advances are enabling truly portable monitors that support mobile donation drives, community outreach programs, and bedside procedures where space and mobility matter.

Data integration has emerged as a defining theme. Modern monitors are increasingly designed to communicate with laboratory information systems, transfusion management platforms, and electronic health records. This interoperability improves traceability, accelerates reconciliation of collection metadata, and allows analytics-driven quality improvement. Parallel to this, algorithmic decision support and embedded sensors are enhancing diagnostic reliability and reducing the likelihood of pre-analytical errors.

Supply chain and procurement paradigms are also shifting. Organizations are moving from single-purchase transactions toward lifecycle agreements that bundle devices, disposables, and support services. This change reflects a broader emphasis on operational continuity and predictable total cost of ownership. Finally, patient- and donor-centric design, including ergonomics and simplified user interfaces, is gaining prominence as health systems work to improve experience and participation rates. Taken together, these shifts are altering both product roadmaps and the expectations of clinical stakeholders, requiring agile responses from manufacturers and purchasers alike.

Comprehensive assessment of how recent United States tariff measures are influencing device sourcing supply chains and strategic procurement decisions through 2025

The 2025 tariff environment in the United States has created a new layer of complexity for device manufacturers, distributors, and clinical buyers. Tariffs on certain device components and finished goods have compelled organizations to reassess sourcing strategies, re-evaluate supplier risk profiles, and explore options for localized manufacturing or alternate shipping routes to mitigate cost exposure. These measures, while targeted, have ripple effects across procurement cycles and inventory planning horizons.

In response, many manufacturers have accelerated supplier qualification programs, prioritized dual-sourcing for critical components, and invested in nearshoring initiatives to shorten lead times and reduce tariff vulnerability. For some stakeholders, longer-term contracts with domestic assemblers offer a hedge against future policy shifts, even when near-term cost differentials exist. Meanwhile, logistics providers and contract manufacturers have adjusted their value propositions to emphasize tariff optimization, customs expertise, and harmonized compliance documentation.

Clinicians and purchasing teams are also adapting. Procurement teams now incorporate tariff risk into vendor evaluations, considering both immediate price impacts and the administrative burden associated with customs classification and compliance. As a result, procurement decisions increasingly weigh supply continuity and service-level guarantees alongside device performance and clinical fit. In short, tariff-related policy changes have elevated supply chain resilience and procurement agility to the forefront of strategic planning for blood collection monitor stakeholders.

Segmentation-driven insights clarifying product collection modes applications and end-use dynamics to guide product strategy and service alignment

Segment-level dynamics reveal differentiated opportunities and operational considerations across product types, collection modes, applications, and end-use environments. Fixed blood collection monitors remain foundational in centralized facilities where throughput and integration with laboratory systems are priorities, while portable blood collection monitors drive outreach, mobile donation, and bedside flexibility where mobility and battery life are critical design constraints.

Collection mode delineation highlights the trade-offs between automated collection and manual approaches. Automated collection streamlines workflow, reduces variability, and can improve donor safety, but it requires higher-capacity support and training. Manual collection retains value in low-volume settings and where simplicity or cost containment is paramount, yet it places greater reliance on operator skill and standardized procedures to maintain quality.

Application-focused segmentation demonstrates that devices used primarily for blood donation must balance donor comfort, throughput, and registry integration, whereas blood storage and testing applications emphasize sample handling integrity, labeling accuracy, and traceable metadata. Research laboratories demand flexible data capture and protocol adaptability to support experimental workflows. Each application imposes distinct performance and compliance requirements that inform product configuration and service offerings.

End-use settings shape procurement priorities and total lifecycle choices. Ambulatory surgical centers prioritize compact footprint, ease of sterilization, and rapid turnover. Blood banks emphasize high-volume reliability, inventory integration, and regulatory compliance. Clinics may favor multi-purpose devices that can serve diverse workflows with minimal training, while hospitals often require scalable solutions that integrate closely with hospital information systems and centralized logistics. Recognizing these segmentation nuances enables more precise product positioning, clinical adoption strategies, and value propositions.

Regional dynamics across major global zones illuminating demand patterns regulatory environments and adoption pathways for blood collection monitors

Regional dynamics are shaped by variation in healthcare infrastructure, regulatory regimes, reimbursement models, and programmatic priorities. In the Americas, mature blood donation networks, established regulatory frameworks, and significant investment in clinical informatics drive demand for high-throughput, interoperable monitors. The emphasis in many institutions is on integration with existing transfusion and laboratory systems, optimizing donor flow, and supporting national blood safety initiatives.

In the Europe, Middle East & Africa region, heterogeneity dominates. Advanced healthcare systems in some countries adopt sophisticated device integrations and emphasize stringent regulatory compliance, whereas emerging healthcare markets focus on affordability, robustness, and ease of maintenance. Donor recruitment models and centralized blood services in parts of this region prioritize portable solutions that can support outreach across wide geographies and varying infrastructure conditions.

Asia-Pacific presents a diverse set of adoption pathways driven by rising healthcare investment, rapid urbanization, and expansion of community health services. Certain markets are rapidly adopting digital health architectures that facilitate monitor interoperability and remote monitoring of collection campaigns, while others prioritize ruggedized portable devices to support remote clinics and large-scale donation drives. Across the regions, regulatory convergence on quality and traceability is progressing, but local pathways and procurement rules continue to influence acquisition timing and supplier selection.

Competitive intelligence and collaborative trends revealing how manufacturers startups and service providers are adapting through innovation and partnerships

Competitive dynamics in the sector reflect a blend of incumbency, focused new entrants, and strategic partnerships. Established medical device manufacturers leverage scale, service networks, and legacy integrations to maintain presence in high-volume institutional settings. At the same time, smaller technology-focused companies and startups often drive incremental innovation in user interface design, sensor integration, and data connectivity, challenging incumbents to modernize rapidly.

Partnership models are increasing in importance. Collaborations between device makers and software providers create differentiated solutions that extend beyond hardware to encompass analytics and operational dashboards. Similarly, alliances with contract manufacturers and logistics specialists allow firms to offer bundled procurement packages that address total lifecycle needs. Investors and corporate development teams are actively exploring acquisitions and licensing arrangements to accelerate access to novel technologies or to broaden consumable ecosystems.

Service propositions-warranties, training, remote diagnostics, and consumable supply agreements-play a decisive role in customer retention and long-term revenue predictability. Firms that pair robust clinical evidence with strong post-sale support and clear interoperability roadmaps are best positioned to capture institutional budgets tied to long-term clinical outcomes and operational efficiency.

Practical prioritized recommendations for industry leaders to accelerate adoption de-risk supply chains and capitalize on emerging clinical workflows

Industry leaders should prioritize a multi-dimensional response that balances innovation, supply resilience, and clinical integration. First, invest in modular product architectures that allow rapid adaptation of sensors, connectivity modules, and consumables to meet differing clinical and regulatory needs. This modularity reduces time-to-update and supports targeted customization for distinct end-use environments.

Second, deepen supplier diversification and near-term onshoring where feasible to reduce exposure to tariff and logistics volatility. Establish clear service-level agreements with alternate suppliers and incorporate tariff sensitivity into procurement scenarios to maintain continuity of operations. Third, accelerate interoperability by adopting open-data standards and establishing clear integration roadmaps with hospital and laboratory information systems; this enhances device utility and reduces adoption resistance from IT stakeholders.

Fourth, build compelling service bundles that combine training, remote diagnostics, and predictable consumable supply to shift procurement conversations from one-time purchases to value-based partnerships. Fifth, pursue focused clinical evidence programs that demonstrate improvements in collection quality, donor experience, and operational efficiency; prioritized evidence will facilitate positive procurement decisions and reimbursement conversations. Finally, cultivate flexible go-to-market approaches that align direct sales, distributor partnerships, and clinical partnerships to reach diverse end users effectively.

Rigorous research methodology combining primary interviews technical review and supply chain analysis to ensure comprehensive and verifiable findings

This research synthesizes qualitative and quantitative inputs derived from primary interviews, technical document review, and secondary data sources to produce a comprehensive perspective on the sector. Primary research included structured interviews with procurement officers, clinical leads, laboratory managers, device engineers, and regulatory experts to capture operational priorities, clinical workflows, and compliance concerns.

Secondary research encompassed regulatory guidance, standards documentation, device specification sheets, and published clinical studies to validate technical claims and contextualize performance expectations. Supply chain mapping and tariff impact analysis were performed using customs classification references, logistics timelines, and supplier network assessments to identify vulnerability points and mitigation strategies.

Triangulation of findings was achieved by cross-referencing interview insights with documented device capabilities and regulatory requirements, while advisory review by subject matter experts ensured interpretive rigor. The methodology emphasizes transparency in source types and analytical assumptions, enabling readers to trace how conclusions were reached and to understand the evidentiary basis for recommended actions.

Concise conclusion synthesizing strategic implications persistent challenges and the near-term priorities for stakeholders in blood collection monitoring

The cumulative analysis underscores that blood collection monitors occupy a strategic position within contemporary care delivery and transfusion systems. Technology innovation, from automation to data integration, offers tangible opportunities to enhance collection quality, donor safety, and operational efficiency. Meanwhile, policy shifts and supply chain complexity require proactive procurement and manufacturing strategies to preserve continuity and control costs.

Segmentation and regional nuances indicate that no single product approach will satisfy all needs; instead, successful strategies combine adaptable hardware, interoperable software, and robust service models tailored to clinical and geographic contexts. Competitive dynamics favor organizations that can marry technical performance with lifecycle services and demonstrable clinical value.

Overall, stakeholders who act decisively to integrate modular design principles, strengthen supplier networks, and produce prioritized clinical evidence will be best positioned to navigate near-term policy headwinds and to capture the long-term benefits of evolving clinical workflows. The report provides the operational detail needed to translate this strategic perspective into concrete procurement and product development plans.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Monitor Market, by Product

  • 8.1. Fixed Blood Collection Monitors
  • 8.2. Portable Blood Collection Monitors

9. Blood Collection Monitor Market, by Collection Mode

  • 9.1. Automated Collection
  • 9.2. Manual Collection

10. Blood Collection Monitor Market, by Application

  • 10.1. Blood Donation
  • 10.2. Blood Storage
  • 10.3. Blood Testing
  • 10.4. Research Laboratories

11. Blood Collection Monitor Market, by End-Use

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Blood Banks
  • 11.3. Clinics
  • 11.4. Hospitals

12. Blood Collection Monitor Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Collection Monitor Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Collection Monitor Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Collection Monitor Market

16. China Blood Collection Monitor Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Becton, Dickinson and Company
  • 17.6. Boeckel + Co (GmbH + Co.) KG
  • 17.7. Cardinal Health Inc.
  • 17.8. Delcon SRL
  • 17.9. Fresenius Kabi AG
  • 17.10. Greiner Group AG
  • 17.11. Grifols, S.A.
  • 17.12. GVS, S.p.A.
  • 17.13. Inspira Technologies Oxy B.H.N. Ltd.
  • 17.14. Krew Instruments Pvt Ltd
  • 17.15. Kriya Medical Technologies
  • 17.16. Labcold Ltd.
  • 17.17. Labotronics Scientific LTD.
  • 17.18. Labtop Instruments Pvt . Ltd .
  • 17.19. Labtron Equipment Ltd
  • 17.20. Lasany International Inc
  • 17.21. Lmb Technologie GmbH
  • 17.22. Medline Industries, Inc.
  • 17.23. Mitra Industries
  • 17.24. Narang Medical Limited
  • 17.25. Nigale Biomedical Inc. (NBM)
  • 17.26. Nipro Corporation
  • 17.27. REMI GROUP
  • 17.28. Sarstedt AG & Co. KG
  • 17.29. Terumo Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION MONITOR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD COLLECTION MONITOR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD COLLECTION MONITOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD COLLECTION MONITOR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY FIXED BLOOD COLLECTION MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY FIXED BLOOD COLLECTION MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY FIXED BLOOD COLLECTION MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY PORTABLE BLOOD COLLECTION MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY PORTABLE BLOOD COLLECTION MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY PORTABLE BLOOD COLLECTION MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY AUTOMATED COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY AUTOMATED COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY AUTOMATED COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY MANUAL COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY MANUAL COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY MANUAL COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD DONATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD DONATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD DONATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS BLOOD COLLECTION MONITOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 45. AMERICAS BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 50. NORTH AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 55. LATIN AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. MIDDLE EAST BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 75. AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 86. ASEAN BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 89. GCC BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GCC BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. GCC BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 92. GCC BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. GCC BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPEAN UNION BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. BRICS BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 104. G7 BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. G7 BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 106. G7 BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 107. G7 BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. G7 BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 109. NATO BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NATO BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 111. NATO BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 112. NATO BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. NATO BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD COLLECTION MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES BLOOD COLLECTION MONITOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 117. UNITED STATES BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA BLOOD COLLECTION MONITOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA BLOOD COLLECTION MONITOR MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 122. CHINA BLOOD COLLECTION MONITOR MARKET SIZE, BY COLLECTION MODE, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA BLOOD COLLECTION MONITOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA BLOOD COLLECTION MONITOR MARKET SIZE, BY END-USE, 2018-2032 (USD MILLION)